Fidelis Insurance increases common share repurchase authorisation to $400m

Bermuda-based global specialty insurance and reinsurance company Fidelis Insurance Group has expanded its capital management program by increasing its current common stock repurchase authorization to $400 million.

The expanded program allows companies to repurchase shares through open market purchases, accelerated share repurchases or privately negotiated transactions.

Before that, 2025 was a big year for shareholder returns, with Fidelis returning $313.7 million to investors.

This total includes the repurchase of 15,184,976 shares of common stock for $261.4 million and dividends of $52.3 million.

Notably, shares repurchased in the fourth quarter of 2025 included 4,075,726 shares of common stock repurchased through two privately negotiated transactions with CVC Falcon Holdings Limited for a total of $75 million.

In addition, the Company’s Board of Directors approved and declared a dividend of $0.15 per common share on March 27, 2026, to shareholders of record on March 16, 2026.

Fidelis noted that the timing and amount of future buybacks will remain at its discretion, depending on market conditions, share price, liquidity and internal assessment of the company’s intrinsic value.

The program is flexible and can be suspended or terminated by the board at any time.

“We are first and foremost a strategic capital allocator, focused on identifying the most compelling opportunities and prioritizing initiatives that drive shareholder value creation,” said Dan Burrows, CEO of Fidelis Insurance Group.

“With our strong capital position, we will continue to pursue attractive underwriting opportunities – whether through new partnerships to drive growth or with the Fidelis Partnership – while also returning capital to our shareholders through dividends and highly accretive repurchases.”

See also  3 Reasons Insurance Professionals Should Read “Pay Up”

Barros further commented: “Today’s announcement of an increase in our common stock repurchase authorization provides us with additional flexibility to take advantage of the significant discount between current stock prices and net book value. We look forward to continuing to execute repurchases opportunistically in the open market and through privately negotiated transactions while returning capital to shareholders.”

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page